Events Partner Content The 3rd Annual RNAi – Based Therapeutics Summit Returns! successfully develop targeted extrahepatic RNAi drugs
Digital Digital innovation drives vaccine development It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovatio
Events Partner Content 2nd Mitochondria-Targeted Drug Development Summit Therapies for mitochondrial dysfunction
Events Partner Content Next Generation Kinase Inhibitors Summit Advance Targeting of the Kinome to Overcome Resistance
Events Partner Content 6th Microbiome Movement - Drug Development Summit Europe New generation of microbiome-targeted therapeutics
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
